Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FERINJECT in Colorectal Adenocarcinoma Related Anaemia
NCT02057471Phase 4Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Sep 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric carboxymaltose in anemia, sponsored by Nottingham University Hospitals. Primary endpoints: Number of patients transfused allogenic red blood cells at 4 weeks and Hemoglobin levels at 10 weeks. Started Sep 2009; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02057471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057471.